Oral agents in the management of type 2 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  American Family Physician

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 11352285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combining sulfonylureas and other oral agents.

  2000cited by this paper
• Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report

  2000cited by this paper
• Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

  2000cited by this paper
• Combining insulin and oral agents.

  2000cited by this paper
• Hepatic Failure in a Patient Taking Rosiglitazone

  2000cited by this paper
• Rosiglitazone taken once daily provides effective glycaemic control in patients with Type 2 diabetes mellitus

  2000cited by this paper
• Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes.

  1999cited by this paper
• The use of insulin secretagogues in the treatment of type 2 diabetes.

  1999cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Therapy of type 2 diabetes, cardiovascular death, and the UGDP.

  1999cited by this paper
• Pharmacologic Therapy for Type 2 Diabetes Mellitus

  1999influential reference
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Treatment of type 2 diabetes mellitus.

  1998cited by this paper
• Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994

  1998cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Troglitazone Use in Insulin-Treated Type 2 Diabetic Patients

  1998cited by this paper
• Triple oral antidiabetic therapy in type 2 diabetes mellitus.

  1998cited by this paper
• Beginning Insulin Treatment of Obese Patients With Evening 70/30 Insulin Plus Glimepiride Versus Insulin Alone

  1998cited by this paper
• Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM

  1997cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Glycemic control in diabetes mellitus: have changes in therapy made a difference?

  1996cited by this paper
• The Pharmacological Treatment of Hyperglycemia in NIDDM

  1996cited by this paper
• Thiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes

  1996cited by this paper
• Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.

  1996cited by this paper
• Clinical experience with acarbose: results of a Canadian multicentre study.

  1995cited by this paper
• Metabolic effects of metformin in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

  1995cited by this paper
• Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

  1995cited by this paper
• One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.

  1994cited by this paper
• The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

  1994cited by this paper
• The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus

  1994cited by this paper
• Double-Blind Evaluation of Efficacy and Tolerability of Metformin in NIDDM

  1991cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper

• Investigation of Dissolution Failures of Metformin Delayed-Release Tablets During Formulation Design

  2025cites this paper
• Efficacy and Safety of DPP-4 Inhibitors and Metformin Combinations in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis

  2024cites this paper
• Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review

  2024cites this paper
• Postprandial Plasma Glucose between 4 and 7.9 h May Be a Potential Diagnostic Marker for Diabetes

  2024cites this paper
• Drug Repurposing of FDA Compounds against α-Glucosidase for the Treatment of Type 2 Diabetes: Insights from Molecular Docking and Molecular Dynamics Simulations

  2023cites this paper
• Role of obesity related inflammation in pathogenesis of peripheral artery disease in patients of type 2 diabetes mellitus

  2023cites this paper
• An update on diagnosis and therapeutics for type-2 diabetes mellitus

  2023cites this paper
• Antihyperglycemic, Antihyperlipidemic and Antioxidant Effects of Eclipta prostrata L. Aqueous Extract in Streptozotocin-Induced Diabetic Rats

  2022cites this paper
• Recent Progress in the Diagnosis and Management of Type 2 Diabetes Mellitus in the Era of COVID-19 and Single Cell Multi-Omics Technologies

  2022cites this paper
• Management of Phosphatidylinositol-3-Kinase Inhibitor-Associated Hyperglycemia

  2022cites this paper
• Radical Scavenging and Antioxidant Effects of Garlic Oil and Vitamin E in Streptozotocin-Induced Diabetic Rats

  2021cites this paper
• Reprotoxic activities of vildagliptin administration in male Wistar rats

  2021cites this paper
• Preoperative Management of Diabetic Patients, an Overview

  2021cites this paper
• Evaluation of Anti-diabetic Effects of Eryngium Billardieri on Streptozotocin-induced Diabetes in Male Mice

  2021cites this paper
• A Review on Drug Related Problems in Type 2 DM with Combination of Sulfonylureas and Biguanides

  2021cites this paper
• Lactiplantibacillus plantarum MG4296 and Lacticaseibacillus paracasei MG5012 Ameliorates Insulin Resistance in Palmitic Acid-Induced HepG2 Cells and High Fat Diet-Induced Mice

  2021cites this paper
• Targeting mangiferin loaded N-succinyl chitosan-alginate grafted nanoparticles against atherosclerosis - A case study against diabetes mediated hyperlipidemia in rat.

  2021cites this paper
• Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches

  2021cites this paper
• Antidiabetical and hypoglycemic action of mushroom polysaccharides

  2020cites this paper
• Review on Metformin Effect on Male Reproductive System

  2020cites this paper
• Antidiabetic Screening, Activity-guided Isolation and Molecular Docking Studies of Flower Extracts of Pongamia pinnata (L.) Pierre

  2020cites this paper
• Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial.

  2020cites this paper
• "Incidence and Prevalence of Hypoglycaemia in Type 1 and Type 2 Diabetes Individuals: A Systematic Review and Meta-analysis".

  2020cites this paper
• Current strategies used for better management of Type-2 diabetes mellitus

  2020cites this paper
• Anti-hyperglycemic activity of myricetin, through inhibition of DPP-4 and enhanced GLP-1 levels, is attenuated by co-ingestion with lectin-rich protein

  2020cites this paper
• Activity And Kinetics of α-Glucosidase Inhibition by Collagen Hydrolysate From Thunnus albacares Bone

  2019cites this paper
• The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats.

  2019cites this paper
• Diabetes Mellitus

  2019cites this paper
• Cost-Effectiveness Analysis of Oral Hypoglycemics for Type-2 Diabetes Mellitus at a Tertiary Care Hospital, Nepal

  2019cites this paper
• Comparative assessment of the ef icacy of voglibose andmetformin combined with insulin in patients with type 2 diabetes mellitus

  2019cites this paper
• α-Glucosidase inhibitory activity and in vivo antihyperglycemic effect of secondary metabolites from the leaf infusion of Ocimum campechianum mill.

  2019cites this paper
• A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents.

  2019cites this paper
• Antihyperlipidemic Effect of Solanum incanum on Alloxan Induced Diabetic Wistar Albino Rats

  2018cites this paper
• Diabetes : The next epidemic ?

  2018cites this paper
• Dietary Flavonoids in the Prevention of T2D: An Overview

  2018cites this paper
• Analysis of in Vitro and in silico Anti-Hyperglycaemic Action of Bioflavonoids Isolated from Different Citrus Peels

  2018cites this paper
• Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus

  2018cites this paper
• Redefining the Therapeutic Wheel of Diabetes Management

  2018cites this paper
• Flavonoids Fraction of Mespilus Germanica Alleviates Insulin Resistance in Metabolic Syndrome Model of Ovariectomized Rats via Reduction in Tumor Necrosis Factor-α

  2018cites this paper
• Fasting blood sugar and clinical biochemistry profiles of diabetic rats treated with methanol leaf extract of Gnetum africanum Welw.

  2018cites this paper
• Allele-Specific Detection of SLC22A2 rs316019 Variants Associated with Metformin Disposition through the Kidney

  2018cites this paper
• Hypoglycemic potential of combined ethanol extracts of gongronema latifolia and vernonia amygdalina leaf in alloxan-induced diabetic albino wistar rats

  2018cites this paper
• Review on microspheres as a drug delivery carrier

  2017cites this paper
• Multicentre Evaluation of Adherence to Extended-Release Metformin in Daily Practice in Russia

  2017cites this paper
• PHARMACEUTICAL APPLICATION OF MICROSPHERES: AN APPROACH FOR THE TREATMENT OF VARIOUS DISEASES

  2017cites this paper
• Glycemic Pentad Glycemic Pentad Forum

  2017cites this paper
• Biomedical Applications of Microspheres

  2017cites this paper
• Cinnamic Acid Derivatives as α-Glucosidase Inhibitor Agents

  2017cites this paper
• Cinnamic Acid Derivatives as Antidiabetics Agents

  2017cites this paper
• Anti-hyperglycemic potential of Lactobacillus spp. in alloxan-induced Wistar rats.

  2017cites this paper
• Comparative evaluation of antidiabetic potential of partially purified bioactive fractions from four medicinal plants in alloxan-induced diabetic rats

  2017cites this paper
• The How-To for Type 2: An Overview of Diagnosis and Management of Type 2 Diabetes Mellitus.

  2017cites this paper
• Understanding Pregnancy Centered Medications: Characterizing the Interactions of a Series of Sulfonylurea Analogs and the ATP Binding Cassette Transporter Proteins, P-Glycoprotein and Breast Cancer Resistance Protein

  2017cites this paper
• Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.

  2017cites this paper
• Effects of anti-diabetic pharmaceuticals to non-target species in freshwater ecosystems: A review

  2017cites this paper
• Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview

  2017cites this paper
• Hypoglycemic potential of herbal product dolabi compared with pioglitazone in streptozotocin-induced diabetic rats

  2016cites this paper
• Review-Medicinal plants and management of Diabetes Mellitus: A review.

  2016cites this paper
• Effects of Lactobacillus plantarum CCFM0236 on hyperglycaemia and insulin resistance in high‐fat and streptozotocin‐induced type 2 diabetic mice

  2016cites this paper
• CHARACTERIZATION OF EXTRACTION METHODS TO RECOVER PHENOLIC-RICH EXTRACTS FROM PINTO BEANS (BAJA) THAT INHIBIT ALPHA-AMYLASE AND ALPHA-GLUCOSIDASE USING RESPONSE SURFACE APPROACHES

  2016cites this paper
• Tissue Engineering of Pancreatic Construct using Stem cells and Biomimetic Construct

  2016cites this paper
• Study on AAV-mediated gene therapy for diabetes in humanized liver mouse to predict efficacy in humans.

  2016cites this paper
• Prevalence and Incidence of Diabetes Mellitus in rural areas of Sindh Province of Pakistan

  2016cites this paper
• Diterpenes-A Review on Therapeutic uses with special emphasis on Antidiabetic Activity

  2016cites this paper
• GLOBAL CURRENT TRENDS IN NATURAL PRODUCTS FOR DIABETES MANAGEMENT: A REVIEW Review Article

  2016cites this paper
• A Prospective Study to Analyse the Metabolic Effect of Metformin with Glimepiride on Type 2 Diabetic Patients of North India.

  2016influential citation
• Antidiabetic effect of ligustilide-rich total lactones derived from Shunaoxin dropping pills on mice with type 2 diabetes induced by a high-fat diet and streptozotocin

  2016cites this paper
• Antioxidant and antidiabetic activities of the seed and leaf extracts of Chrysophyllum albidum

  2016cites this paper
• Antihyperglycemic and Antiobesity Effects of JAL2 on db/db Mice

  2016cites this paper
• Gedunin and Azadiradione: Human Pancreatic Alpha-Amylase Inhibiting Limonoids from Neem (Azadirachta indica) as Anti-Diabetic Agents

  2015cites this paper
• Influence of disease and drug risk factors on metformin dose adjustment: A retrospective study of outpatients in Nablus.

  2015cites this paper
• Antihyperglycemic effect of ipragliflozin, a sodium‐glucose co‐transporter 2 inhibitor, in combination with oral antidiabetic drugs in mice

  2015influential citation
• Biochemical and hematological indices of normal human subjects, pre-treatment, and combined therapy (semi-vegan diet and metformin)-administered diabetic patients of Imo State University Teaching Hospital Orlu, Nigeria

  2015cites this paper
• GLP-1 secretagogues potential of medicinal plants in management of diabetes

  2015cites this paper
• Phytochemical Screening, Acute Toxicity study and Evaluation of Antidiabetic properties of the methanolic leaf extract of Vernonia glaberrima (Asteraceae)

  2015cites this paper
• Diabetes mellitus – an overview

  2015cites this paper
• Effect of metformin on global phosphorylation profiles of primary skeletal muscle cells derived from overweight/obese insulin resistant human participants

  2015cites this paper
• Antihyperglycemic activity of Zanthoxylum chalybeum stem bark extract in diabetic rats

  2015cites this paper
• Hormones Part 2: Insulin and Other Glucose-Controlling Medications

  2015cites this paper
• CURRENT TREATMENTS FOR TYPE 2 DIABETES, THEIR SIDE EFFECTS AND POSSIBLE COMPLEMENTARY TREATMENTS

  2015cites this paper
• Anti-Diabetic Effect of Aster sphathulifolius in C57BL/KsJ-db/db Mice

  2015cites this paper
• The antidiabetic properties of four plants grown in India and KwaZulu-Natal, South Africa, suitable for diabetic management

  2015cites this paper
• Intracerebroventricular Metformin Decreases Body Weight But Has Pro-oxidant Effects and Decreases Survival

  2015cites this paper
• Exploring the role of glucagon in glucose homeostasis

  2015cites this paper
• New Onset Diabetes Mellitus after Living Donor Renal Transplantation: A Unique Pattern in the Egyptian Population

  2015cites this paper
• Demirtas wing spot test Drosophila Genotoxic evaluation of two oral antidiabetic agents in the

  2014cites this paper
• Genotoxic evaluation of two oral antidiabetic agents in the Drosophila wing spot test

  2014cites this paper
• Outline about Biological and Chemical Coordinations of Some Sulphonyl Drugs

  2014cites this paper
• Simultaneous determination of bosentan and glimepiride in human plasma by ultra performance liquid chromatography tandem mass spectrometry and its application to a pharmacokinetic study.

  2014cites this paper
• Polyherbal extracts of Vernonia amygdalina, Moringa oleifera, Gongronema latifolium and Ocimum gratissimum may substitute insulin requirement in the long term management of type 1 diabetes

  2014cites this paper
• imultaneous determination of bosentan and glimepiride in human lasma by ultra performance liquid chromatography tandem mass pectrometry and its application to a pharmacokinetic study

  2014cites this paper
• PREVALENCE OF INSULIN-TREATED TYPE 2 DIABETES MELLITUS IN NORTHERN JORDAN: LIFE STYLE, FAMILIAL INHERITANCE AND MATERNAL INFLUENCE

  2014cites this paper
• Dietary, Physical Activity and Other Lifestyle Habits and their Associations with Medication Adherence in a Group of Hypercholesterolemic Patients Prescribed Statin Therapy in Kuwait

  2014cites this paper
• Antidiabetic effect of Lactobacillus casei CCFM0412 on mice with type 2 diabetes induced by a high-fat diet and streptozotocin.

  2014cites this paper
• Prescription patterns for pacific patients with poor cardiovascular disease medication supply

  2014cites this paper
• Targeting SUMOylation cascade for diabetes management.

  2014cites this paper
• Oral antihyperglycaemic agents in type 2 diabetes mellitus : review

  2014cites this paper
• Development and Validation of the Chinese Attitudes to Starting Insulin Questionnaire (Ch-ASIQ) for Primary Care Patients with Type 2 Diabetes

  2013cites this paper
• Title Development and Validation of the Chinese Attitudes to Starting Insulin Questionnaire ( Ch-ASIQ ) for Primary Care Patients with Type 2 Diabetes

  2013cites this paper
• Carbamazepine as a Novel Small Molecule Corrector of Trafficking-impaired ATP-sensitive Potassium Channels Identified in Congenital Hyperinsulinism*

  2013cites this paper